Long Island has a ‘high burden’ for a common blood disorder: new study
A new study by researchers at NYU School of Global Public Health found that Long Island has a high burden of sickle cell disease (SCD), with the highest percentage of hospitalizations carrying a major risk of death among New York regions. The study analyzed 42,200 SCD hospitalizations in New York between 2009 and 2022, revealing disparities in care, costs, and outcomes across regions. Researchers suggest the findings can help improve access to specialized care and inform public health policy to reduce the strain on emergency departments and improve patient outcomes.
Opening excerpt (first ~120 words) tap to expand
Health Long Island has a ‘high burden’ for a common blood disorder: new study By Reda Wigle Published May 1, 2026, 11:27 a.m. ET About 100,000 Americans have sickle cell disease (SCD), the most common inherited blood disorder in the US. Roughly 10% of patients reside in New York State, with the majority living in NYC, researchers at NYU School of Global Public Health found. Using data from 42,200 SCD hospitalizations in the state between 2009 and 2022, researchers assessed the length of hospital stays, total charges, severity of illness and risk of death. 3 Sickle cell disease, which affects roughly 100,000 Americans, is an inherited blood disorder caused by a mutated gene.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at New York Post.
Discussion
0 commentsMore from New York Post
